Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Induction Therapy for Deceased Donor Kidney Transplant Recipients
NCT02495077Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2015
- Primary completion
- Jul 2021
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of infliximab in kidney transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2015; status: completed.
02
Drugs
infliximab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02495077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495077.